Why drugs lopinavir and hydroxychloroquine do not work on COVID-19
Lopinavir is a drug against HIV; hydroxychloroquine is used to treat malaria and rheumatism.
Until recently, both drugs were regarded as potential agents in the...
This single-dose flu drug can reduce virus spread within households
In a new study, researchers found a single dose of the flu drug baloxavir marboxil can reduce the spread of the illness within households.
Baloxavir...
COVID-19 linked to these mental problems, new study shows
In a new study, researchers found people who have or had COVID-19 symptoms are more likely to develop general psychiatric disorders and are lonelier,...
Scientists develop a much less addictive painkiller to reduce pain
In a new study, researchers found a potential new opioid medication may have the ability to slow the progression of osteoarthritis while being less...
This mental problem can help predict dementia
In a new study, researchers found apathy offers an important early warning sign of dementia in individuals with cerebrovascular disease, but depression does not.
The...
New COVID-19 vaccine shows promise in early experiments
In a new study, researchers announced positive results from the preclinical studies of its intranasal COVID-19 vaccine candidate, AdCOVID.
The team showed strong serum neutralizing...
This high blood pressure drug may increase heart failure risk
In a new study, researchers found that women taking beta-blockers for hypertension with no prior history of cardiovascular disease (CVD) have a nearly 5%...
These two exercises may be a adjunctive treatment for COVID-19
In a new study, researchers found that the anti-inflammatory and other beneficial effects of meditation and yoga practices make them potential adjunctive treatments of...
This hormone linked to higher blood sugar in type 2 diabetes
In a new study, researchers found a clear link between the stress hormone cortisol and higher blood sugar levels in people with type 2...
This drug could calm ‘cytokine storm’, almost halve COVID-19 death risk
In a new study, researchers found critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system...